Journal Article Summary
The article investigates how aspirin affects transcription factors related to inflammation in atherosclerosis, a condition that significantly contributes to cardiovascular disease and mortality. Atherosclerosis involves chronic inflammation, and understanding how aspirin, commonly known for its blood-thinning properties, can influence inflammatory pathways is crucial. This research aims to clarify aspirin's role beyond its antiplatelet effects, particularly its potential to modulate key transcription factors like NF-κB, PPARs, and AP-2α, which are involved in the inflammatory processes of atherosclerosis.
To conduct this systematic review, the authors searched various databases for studies published between 1980 and 2025 that examined aspirin's effects on inflammation-related transcription factors in atherosclerosis. They identified 102 studies, ultimately focusing on those that reported on the modulation of NF-κB, PPARs, and AP-2α. The findings suggest that aspirin inhibits NF-κB activation, reduces the production of pro-inflammatory cytokines, and enhances the signaling of PPARs and AP-2α, which may contribute to its anti-inflammatory and plaque-stabilizing effects. However, the clinical outcomes of aspirin use in cardiovascular health appear to vary based on dosage and patient characteristics.
The review acknowledges several limitations, including the variability in study designs and the need for more extensive research on the specific roles of AP-2α and PPARs in aspirin's effects. Additionally, the authors highlight that aspirin's efficacy can be influenced by patient-specific factors, such as the presence of diabetes or chronic kidney disease, which may alter inflammatory responses. Patients should discuss their individual health conditions and the potential benefits and risks of aspirin therapy with their healthcare providers to ensure personalized and safe treatment strategies.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Aghaei Mojtaba, Khademi Reyhane, Bahreiny Seyed Sobhan, Haybar Habib, Torfi Ekhlas, Azizidoost Shirin, Saki Najmaldin. Potential Effects of Aspirin on Transcription Factors Related to the Inflammation in Atherosclerosis: A Systematic Review. Health Science Reports 2026. DOI: 10.1002/hsr2.71950. PMID: 41970431. PMCID: PMC13062501.
Featured Pill Pals Product
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs --- Over The Counter
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over — Generic For Bayer Low Dose — Time Cap Labs — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
